Alpha-1 Liver Disease: What is It, Who Gets It, and How Do We Manage It
Liver: Patient Panel Facilitated
Alpha-1 Liver Disease: An Overview of the Epidemiology,
Diagnosis and Therapeutic Options for Liver Disease in Children and Adults
Traveling From: Charleston, SC
Profile:
Dr. Reuben, MBBS, FRCP, FACG, is the author of over 120 original articles, editorial reviews, book chapters, and case reports. He lectures widely on liver disease, and participates in many national and international conferences. Dr. Reuben has been as associate editor of Hepatology and is on the editorial boards of Liver Transplantation and the World Journal of Gastroenterology.
In this session, you’ll learn how Alpha-1 Antitrypsin liver disease affects patients of both genders from infancy to adulthood, and all races. Unlike the lung disease associated with Alpha-1, liver disease results from the toxic effects of defective Alpha-1 Antitrypsin protein that is retained in the liver, where it is made.
Learning Objectives
To describe the clinical manifestations of Alpha-1 liver disease
To review the epidemiology and patient demographics of Alpha-1 liver disease
To explain the course of Alpha-1 liver disease
For more information please contact us at: 1-800-521-3025
